Helix BioMedix, Inc.
HXBM
$7.18
-$0.01-0.14%
OTC PK
| 09/30/2012 | 06/30/2012 | 03/31/2012 | 12/31/2011 | 09/30/2011 | |
|---|---|---|---|---|---|
| Net Income | 61.22% | 66.50% | 68.50% | 67.73% | -71.36% |
| Total Depreciation and Amortization | -13.52% | -9.54% | -5.12% | -4.13% | -8.44% |
| Total Amortization of Deferred Charges | -15.37% | -61.72% | -93.66% | -- | 27.53% |
| Total Other Non-Cash Items | -94.07% | -94.21% | -92.47% | -94.97% | 395.33% |
| Change in Net Operating Assets | 185.90% | 148.83% | 40.91% | -17.19% | -351.33% |
| Cash from Operations | 28.50% | 29.88% | 28.65% | 17.91% | 11.92% |
| Capital Expenditure | -94.55% | 100.00% | 172.58% | 49.06% | -711.11% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 56.94% | 81.39% | 82.09% | 82.09% | 83.30% |
| Cash from Investing | 53.52% | 83.31% | 89.67% | 83.28% | 81.79% |
| Total Debt Issued | -- | -- | -- | -- | -100.00% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -- | -17.13% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -4,726.75% | -411.77% | -554.00% | -187.25% | 163.59% |